JAZZ PHARMACEUTICALS PLCJAZZ PHARMACEUTICALS PLCJAZZ PHARMACEUTICALS PLC

JAZZ PHARMACEUTICALS PLC

No trades
See on Supercharts

Price target

175.350.000.00%
The 18 analysts offering 1 year price forecasts for J7Z have a max estimate of — and a min estimate of —.

Analyst rating

Based on 21 analysts giving stock ratings to J7Z in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


J7Z EPS for the last quarter is 5.94 EUR despite the estimation of 4.94 EUR. In the next quarter EPS is expected to reach 5.60 EUR. Track more of JAZZ PHARMACEUTICALS PLC financials and stay on top of what is up with the company.
In the next quarter JAZZ PHARMACEUTICALS PLC revenue is expected to reach ‪1.02 B‬ EUR. Check out JAZZ PHARMACEUTICALS PLC revenue and earnings and make informed decisions.
According to analysts, J7Z price target is 175.35 EUR with a max estimate of 223.16 EUR and a min estimate of 124.19 EUR. Check if this forecast comes true in a year, meanwhile watch JAZZ PHARMACEUTICALS PLC stock price chart and keep track of the current situation with J7Z news and stock market news.
We've gathered opinions of 21 analysts rating J7Z stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.